Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
Keywords:
squamous cell carcinoma, head and neck squamous cell carcinoma, skin neoplasms, prognosisReferences
Parekh V, Seykora JT. Cutaneous squamous cell carcinoma. Clin Lab Med. 2017;37(3):503-525. DOI: 10.1016/j.cll.2017.06.003. PMID: 28802498.
Hall ET, Fernandez-Lopez E, Silk AW, Dummer R, Bhatia S. Immunologic characteristics of nonmelanoma skin cancers: implications for immunotherapy. Am Soc Clin Oncol Educ B. 2020;(40):398-407. DOI: 10.1200/edbk_278953. PMID: 32207669.
Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018;78(2):237-247. DOI: 10.1016/j.jaad.2017.08.059. MID: 29332704.
Ascierto PA, Garbe C. Updates and new perspectives in nonmelanoma skin cancer therapy: Highlights from “Immunotherapy Bridge”. Immunotherapy. 2020;12(3):167-174. DOI: 10.2217/imt-2020-0042. PMID: 32208790.
Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol. 2010;3(4):39-48.
Kim RH, Armstrong AW. Nonmelanoma skin cancer. Dermatol Clin. 2012;30(1):125-139. DOI: 10.1016/j.det.2011.08.008. PMID: 22117874.
Waldman A, Schmults C. Cutaneous squamous cell carcinoma. Hematol Oncol Clin North Am. 2019;33(1):1-12. DOI: 10.1016/j.hoc.2018.08.001. PMID: 30497667.
Amin MB, Edge S, Greene F, et al. eds. AJCC Cancer Staging Manual. 8th ed. Springer International Publishing; 2017.
NCCN Clinical Practice Guidelines in Oncology—Squamous Cell Skin Cancer, Version 1.2021. 2021. National Comprehensive Cancer Network. Accessed: 01 April 2021 https://www.nccn.org/ professionals/physician_gls/pdf/squamous.pdf.
Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Cancer Netw. 2010;8(8):836-864. DOI: 10.6004/jnccn.2010.0062. PMID: 20870631.
Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma recurrence,metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(4):419-428. DOI: 10.1001/jamadermatol.2015.4994. PMID: 26762219.
Pyne JH, Barr E, Myint E, Clark SP, David M, Na R. Invasive squamous cell carcinoma: comparison of differentiation grade and tumour depth by anatomical site in 1666 tumours. Clin Exp Dermatol. 2018;43(1):3-10. DOI: 10.1111/ced.13222. PMID: 29064114.
Chapalain M, Baroudjian B, Dupont A, et al. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients. J Eur Acad Dermatol Venereol. 2020;34(6):1202-1209. DOI: 10.1111/jdv.16007. PMID: 31587382.
Amaral T, Osewold M, Presser D, Meiwes A, Garbe C, Leiter U. Advanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patterns. J Eur Acad Dermatol Venereol. 2019;33(S8):44-51. DOI: 10.1111/jdv.15845. PMID: 31658392.
Misiakos EP, Damaskou V, Koumarianou A, et al. A giant squamous cell carcinoma of the skin of the thoracic wall: A case report and review of the literature. J Med Case Rep. 2017;11(1):10-13. DOI: 10.1186/s13256-017-1281-8. PMID: 28494816.
Published
Issue
Section
License
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
